Reuters logo
BRIEF-Caplin Point Laboratories gets U.S. FDA approval for ketorolac tromethamine injection
September 20, 2017 / 4:57 AM / 2 months ago

BRIEF-Caplin Point Laboratories gets U.S. FDA approval for ketorolac tromethamine injection

Sept 20 (Reuters) - Caplin Point Laboratories Ltd

* Says gets FDA approval for ketorolac tromethamine injection 30 mg/ml in U.S.

* Says ketorolac tromethamine injection will be manufactured at Caplin's FDA approved site Source text - bit.ly/2yoo3PA Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below